| 0.0001 -0 (-50%) | 10-23 14:56 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.36 |
1-year : | 0.58 |
| Resists | First : | 0.3 |
Second : | 0.5 |
| Pivot price | 0 | |||
| Supports | First : | 0  |
Second : | 0 |
| MAs | MA(5) : | 0 | MA(20) : | 0 |
| MA(100) : | 0 |
MA(250) : | 0.01 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 66.6 |
D(3) : | 55.5 |
| RSI | RSI(14): 41 |
|||
| 52-week | High : | 1 | Low : | 0 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CLVR ] has closed above bottom band by 40.2%. Bollinger Bands are 96.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0 - 0 | 0 - 0 |
| Low: | 0 - 0 | 0 - 0 |
| Close: | 0 - 0 | 0 - 0 |
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
Fri, 26 Apr 2024
Clever Leaves to delist from Nasdaq and end SEC reporting - Investing.com
Fri, 26 Apr 2024
Clever Leaves Holdings Opts for Nasdaq Delisting and Deregistration - TipRanks
Fri, 26 Apr 2024
Clever Leaves Announces Voluntary Delisting and SEC Deregistration - GlobeNewswire
Mon, 01 Apr 2024
Clever Leaves Reports Fourth Quarter and Full Year 2023 Results - Yahoo Finance
Fri, 05 Jan 2024
Clever Leaves Scores Australian Cannabis GMP Certification - Hemp Gazette
Wed, 03 Jan 2024
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA) - Cannabis Business Times
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 30.7 (%) |
| Held by Institutions | 2.3 (%) |
| Shares Short | 36 (K) |
| Shares Short P.Month | 20 (K) |
| EPS | -12.64 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 14.02 |
| Profit Margin | -102.8 % |
| Operating Margin | -106 % |
| Return on Assets (ttm) | -23.4 % |
| Return on Equity (ttm) | -61.3 % |
| Qtrly Rev. Growth | 5.4 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 9.95 |
| EBITDA (p.s.) | -7.56 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -12 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.01 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|